Alloreactive and autoimmune responses after allogeneic hematopoietic cell transplantation
can occur in nonclassical chronic graft-versus-host disease (chronic GVHD) tissues and …

Axonal loss in multiple sclerosis (MS) is a key component of disease progression and
permanent neurologic disability. MS is a heterogeneous demyelinating and …

Background and Objectives Neurodegeneration and astrocytic activation are pathologic
hallmarks of progressive multiple sclerosis (MS) and can be quantified by serum …

Sensitive and reliable protein biomarkers are needed to predict disease trajectory and
personalize treatment strategies for multiple sclerosis (MS). Here, we use the highly …

Measurement of serum neurofilament light chain concentration (sNfL) promises to become a
convenient, cost effective and meaningful adjunct for multiple sclerosis (MS) prognostication …

Importance The value of serum neurofilament light chain (sNfL) levels for predicting long-
term disability in patients with multiple sclerosis (MS) remains controversial. Objective To …

Neurodegeneration is one of the driving forces behind the pathogenesis of multiple sclerosis
(MS). Progression without activity, pathopsychological disturbances (cognitive impairment …

Background One-off serum levels of neurofilament light chain (sNfL) is an established
predictor of emerging disease activity in multiple sclerosis (MS). However, the importance of …

Multiple sclerosis (MS) is a chronic demyelinating and neuroinflammatory disease of the
human central nervous system with complex pathoetiology, heterogeneous presentations …

The potential for combining serum neurofilament light chain (sNfL) and glial fibrillary acidic
protein (sGFAP) levels to predict worsening disability in multiple sclerosis remains …